WO2003035899A1 - Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood - Google Patents

Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood Download PDF

Info

Publication number
WO2003035899A1
WO2003035899A1 PCT/JP2002/010982 JP0210982W WO03035899A1 WO 2003035899 A1 WO2003035899 A1 WO 2003035899A1 JP 0210982 W JP0210982 W JP 0210982W WO 03035899 A1 WO03035899 A1 WO 03035899A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
bacteria
carbonate
hydroxide
detecting
Prior art date
Application number
PCT/JP2002/010982
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuo Nakatomi
Hatsue Hatano
Original Assignee
Denka Seiken Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denka Seiken Co., Ltd. filed Critical Denka Seiken Co., Ltd.
Priority to JP2003538399A priority Critical patent/JP4227019B2/en
Publication of WO2003035899A1 publication Critical patent/WO2003035899A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components

Definitions

  • the present invention relates to a method for separating blood cells and bacteria contained in a liquid culture medium for detecting bacteria contained in the specimen using blood as a specimen.
  • the culture solution is collected and subjected to Gram staining and morphological observation.
  • Gram staining and morphological observation The general classification of the bacterial species based on the staining findings and morphological characteristics, and whether only one bacterium is observed, Check if there is more than one.
  • a part of the culture is inoculated into a solid medium in which general bacteria grow and cultured. Bacteria grown on the solid medium are subjected to subsequent identification tests, etc.At this time, if the bacteria are a single bacterial species based on gram staining findings, and if the colonies on the solid medium are uniform, they will be present in the blood. Assuming that the type of bacteria used was single (pure culture), the bacteria on the solid medium may be immediately subjected to identification tests, susceptibility tests, etc.
  • the present invention relates to a method of inoculating a part of a culture solution into a solid medium in which general bacteria grow in order to separate bacteria from blood cells and the like in the culture solution when detecting bacteria contained in the sample using blood as a sample.
  • An object of the present invention is to provide a method for separating blood cells and bacteria contained in a liquid culture medium without culturing the cells.
  • the present inventors have found that when bacterial growth is observed in a liquid culture test using blood as a specimen, blood cells, which are blood components, hinder the identification of bacterial species when identifying bacteria in the culture solution.
  • the liquid culture medium containing blood cells, etc. and bacteria was treated with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine.
  • the present inventors have found that blood cells and the like can be removed by bringing them into contact with a mixed aqueous solution thereof and bacteria can be separated from the blood cells and the like, thereby completing the present invention.
  • the present invention is as follows.
  • a method for separating bacteria and blood cells contained in a liquid culture medium of bacteria in blood when detecting bacteria in blood comprising the steps of: Blood cells are removed by contact with metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine aqueous solution, or a mixed aqueous solution of these.
  • a method of separating blood cells and bacteria comprising the steps of: Blood cells are removed by contact with metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine aqueous solution, or a mixed aqueous solution of these.
  • the alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine is selected from the group consisting of sodium hydroxide, hydroxylating ability]] triam and triethanolamine.
  • the method for separating blood cells and bacteria according to any one of (1) to (3).
  • test blood is an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof.
  • a method for removing blood cells from said blood by contacting said blood cells and detecting bacteria in blood from which blood cells have been removed.
  • a method for detecting bacteria in blood comprising culturing a liquid medium inoculated with a test blood to grow the bacteria, and culturing the liquid medium with hydroxide or carbonate of a / potassium metal, alkali metal.
  • a method for detecting bacteria in the liquid medium from which the blood cells have been removed by removing the blood cells in the liquid medium by contacting with an aqueous solution of an earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof.
  • the concentration of the alkali hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine, or a mixture thereof is 0.01 M to 1.0 M.
  • a method for detecting any of the bacteria according to (1) is 0.01 M to 1.0 M.
  • the alkali metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine; 5) A method for detecting any of the bacteria of (8).
  • the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine.
  • the reagent for detecting bacteria is a reagent for detecting bacteria selected from the group consisting of methicillin-resistant Staphylococcus aureus, Escherichia coli 0157 strain, and group A streptococcus,
  • a kit for separating and detecting bacteria in blood according to any one of (11) to (13).
  • the animal species to be used as a subject is not limited, and an animal species having a disease such as sepsis or bacteremia, such as human, pest, poma, bush, dog, cat, etc. is used.
  • bacterium to be used in the present invention include methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa, Enterococcus, Candida, Streptococcus such as streptococcus, etc., but are not particularly limited. All bacteria and fungi correspond to this.
  • the liquid medium includes, but is not limited to, trypticase soy broth, brain heart infusion broth, ordinary bouillon, Mueller-Hinton broth, heart infusion broth, and the like.
  • the culture solution is collected and subjected to Gram staining and morphological observation.
  • Gram staining and morphological observation The general classification of the bacterial species based on the staining findings and morphological characteristics, and whether or not the observed bacteria is single or multiple, etc. Check.
  • the liquid culture medium containing blood cells and bacteria is mixed with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine aqueous solution, or a mixed aqueous solution thereof.
  • alkali metal or alkaline earth metal hydroxides include lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, magnesium hydroxide, calcium hydroxide, strontium hydroxide, and hydroxide. Barium can be mentioned, and among these, lithium hydroxide, sodium hydroxide and potassium hydroxide are preferable.
  • alkali metal or alkaline earth metal carbonates include lithium carbonate, sodium carbonate, potassium carbonate, rubidium carbonate, cesium carbonate, magnesium carbonate, calcium carbonate, strontium carbonate, and barium carbonate. Of these, lithium carbonate, sodium carbonate and potassium carbonate are preferred.
  • Examples of the amine that can be used in the method of the present invention include triethanolamine, tris (hydroxymethyl) aminomethane, and hydroxylamine.
  • the liquid culture broth may be directly contacted with an alkali metal hydroxide or the like, or, once, an appropriate amount of the liquid culture broth is centrifuged, and the supernatant is discarded to obtain a precipitate in which blood cells and bacteria are mixed. Then, the precipitate may be brought into contact with an alkali metal hydroxide or the like.
  • the centrifugal separation at this time is desirably performed at 800 to 5000G.
  • the sediment contains blood cells and bacteria.
  • bacteria are detected by an immunological method, that is, by a detection method using an antibody against the bacteria, a mixture (solution or precipitate) of the blood cells and the bacteria is converted to an alkali metal hydroxide or carbonate, alkaline earth metal, or the like.
  • the blood is used as it is or after being diluted with physiological saline or a suitable buffer, etc., and then an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine.
  • the bacterial gene in the blood can be detected by contact with a mixed aqueous solution thereof.
  • blood or blood diluted with physiological saline or an appropriate buffer is centrifuged to obtain a precipitate containing blood cells and bacteria, and the precipitate is subjected to alkali metal hydroxide or carbonate, alkaline force.
  • Bacterial genes in the blood can also be detected by contact with an aqueous solution of a hydroxide or carbonate of an alkaline earth metal, or an amine, or a mixed aqueous solution thereof.
  • the temperature and time for contacting are not particularly limited, but any conditions may be used as long as blood cells in the blood break down and components constituting the blood cells are dissolved, preferably 2 to 37: several seconds to several minutes, and stirring is performed. It is desirable to make the contact more uniform, in order to further enhance the effect. As a result, the blood cells are destroyed, and the components constituting the blood cells are dissolved in the aqueous solution, but the bacteria are not dissolved.Thus, by centrifuging the cells, it is possible to efficiently separate contaminants such as blood cells. High-purity bacteria can be obtained from the sediment of centrifugation.
  • the pH of the alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the aqueous solution of amine, or the pH of the mixed aqueous solution thereof is such that blood cells in blood break down and blood cells
  • the pH may be any pH at which the constituents of the bacteria are dissolved but the constituents of the bacteria are not dissolved. If the mixture of blood cells and bacteria to be brought into contact with the aqueous solution is sedimented, the pH is preferably 9 or more, and more preferably 10 or more. And particularly preferably 11 or more.
  • the final pH of the solution after the contact is preferably 9 or more, more preferably 10 or more, particularly preferably 11 or more, so that the final pH of the solution is at least 11.
  • An aqueous solution of hydroxide or carbonate of alkaline earth metal or amine, or a mixed aqueous solution thereof may be prepared. This adjustment depends on the volume ratio of the solution containing blood cells and bacteria used for the contact and the hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or the aqueous solution of amine, or a mixed aqueous solution thereof. It can be changed as appropriate. At this time, the concentration of the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the aqueous solution of the amine is preferably such that the pH falls within the above range.
  • the concentration is preferably 0.01 M to 1.0 M.
  • Liquid medium containing blood cells and bacteria When the culture solution is brought into contact with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine, or a mixed aqueous solution thereof, or the blood as it is or physiological saline
  • the concentration of the alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine, or the mixed aqueous solution thereof is adjusted so that the final concentration of the solution after the contact is the above concentration. It should be adjusted. This adjustment is carried out using a solution containing blood cells and bacteria used for the contact, and a hydroxide or carbonate of alkaline metal, a hydroxide or carbonate of alkaline earth metal, or an aqueous solution of amine or a mixture thereof. It can be appropriately changed depending on the volume ratio of the aqueous solution.
  • Bacteria finally obtained by centrifugation from the solution in which the blood cells were disrupted and lysed were MRSA-LA “Seiken” (manufactured by Denrikseiken), pathogenic Escherichia coli immune serum 0157 “Seiken” (manufactured by Denkiseiken), It can be detected using a commercially available agglutination method such as a group A streptococcus detection kit, A-Strept AD “Seiken” (manufactured by Denrikseiken), an ELISA method, or a Western blot method.
  • the DNA of the bacteria can be extracted by known means and detected using a commercially available DNA test reagent. Therefore, by combining the hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or a reagent for detecting an amine or a bacterium, which can be used in the present invention, it is possible to rapidly and accurately detect the blood or blood.
  • a bacteria detection kit capable of detecting the above bacteria can be configured.
  • Example 1 Detection of MRSA (methicillin-resistant Staphylococcus aureus) in blood Blood cultures: anticoagulant was added ⁇ Ma blood lOmL the anonymous SA (methicillin-resistant staphylococci), or MSSA 1 loopful of bacterial suspension containing 10 8 ciuZmL the (methicillin-susceptible Staphylococcus aureus) (0.001 .0015 mL), 8 mL of which was inoculated into a bottle (BBL Septicheck TSB (registered trademark)) containing a liquid culture medium for blood culture, and cultured overnight at 35 ° C.
  • BBL Septicheck TSB registered trademark
  • MRSA strain ANJ-10 [niecA (+) XPCR, MIPPC (R) / KB disc]
  • ATCC43300 [iecA (+) / PCR, MIPPC (R) / KB disc]
  • MSSA strain ATCC25923 [mecA (-) XPCR, MIPPC (S) / KB disc]
  • the sediment obtained here was white, and no blood cells were observed under a microscope.
  • Table 1 shows the results.
  • Blood culture Add 1 loopful (0.001 to 0.0015 mL) of a bacterial solution containing Escherichia coli 0157 or 10 8 cfu / mL of Escherichia coli of another serotype to 10 mL of poma blood supplemented with an anticoagulant. 8 mL of this was inoculated into a bottle (BBL SeptiCheck BHI (registered trademark)) containing a liquid culture medium for blood culture, and cultured overnight at 35 ° C.
  • BBL SeptiCheck BHI registered trademark
  • the sediment obtained here is white and viewed under a microscope. On inspection, no blood cells were observed.
  • Table 2 shows the results. Table 2 Stock judgment
  • T-4 shares Group B streptococcus: Ia strain
  • the sediment obtained here was white, and no blood cells were observed under a microscope.
  • the bacteria in the blood are detected by contacting with an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine
  • an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine By removing the blood cells contained in the liquid culture medium of the bacteria in the blood or in the blood, the blood cells and the bacteria can be efficiently separated.
  • the pH of the aqueous solution to 11 or more, blood cells and bacteria can be more efficiently separated.
  • the concentration of the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the concentration of the amine is 0.01 M to 1.0 M, so that the blood cells can be more efficiently used. And bacteria can be separated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

It is intended to provide a method of separating blood cells from a microorganism contained in blood or a liquid culture medium of blood in case of detecting the microorganism in blood employed as a specimen; a method of detecting a microorganism; and a kit therefor. Namely, a method of separating blood cells from a microorganism contained in blood or a liquid culture medium of blood in case of detecting the microorganism in blood which comprises eliminating the blood cells by bringing into contact with an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate or an amine or an aqueous solution of a mixture thereof; a method of detecting a microorganism with the use of this separation method; and a detection kit.

Description

明細書 血液中の血球と菌の分離方法および血液中の菌の検出方法 技術分野  Description Method for separating blood cells from bacteria in blood and method for detecting bacteria in blood
本発明は血液を検体として該検体に含まれる菌を検出する際の液体培地培養液 中に含まれる血球と菌の分離方法に関するものである。 背景技術  TECHNICAL FIELD The present invention relates to a method for separating blood cells and bacteria contained in a liquid culture medium for detecting bacteria contained in the specimen using blood as a specimen. Background art
血液を検体として該検体に含まれる菌を検出する際の培養は主に敗血症、 菌血 症など血流中に細菌の存在が疑われる場合に行われている。 このような場合、 患 者は重篤であることが多く早急に適切な化学療法が要求される。 従来技術におい て、 敗血症血液検査は次のように行われている。  Culture using blood as a sample to detect bacteria contained in the sample is mainly performed when the presence of bacteria in the bloodstream such as sepsis or bacteremia is suspected. In such cases, patients are often serious and require immediate chemotherapy. In the prior art, a sepsis blood test is performed as follows.
( 1 ) 細菌培養用液体培地約 30mL〜100mLに採取した血液 2〜5 mLを接種し、 直ち に 30〜37°Cで培養する。  (1) Inoculate 2 to 5 mL of blood collected in about 30 to 100 mL of liquid culture medium for bacterial culture, and immediately incubate at 30 to 37 ° C.
( 2 ) 菌の発育が認められるまで 1〜14日間毎日観察を行う。 菌の発育は、 培地 の濁度、 細菌による培地中のガスの発生、 pHの変ィヒなどによって判断する。  (2) Observe daily for 1 to 14 days until bacterial growth is observed. The growth of the bacteria is determined by the turbidity of the medium, the generation of gas in the medium by the bacteria, and the pH change.
( 3 ) 菌の発育が確認された後、 培養液を採取してグラム染色及び形態観察が行 われ、 染色所見と形態の特徴により大まかな菌種の分類、 及び観察される菌が単 一か複数かなどを確認する。  (3) After the growth of the bacteria is confirmed, the culture solution is collected and subjected to Gram staining and morphological observation.The general classification of the bacterial species based on the staining findings and morphological characteristics, and whether only one bacterium is observed, Check if there is more than one.
( 4 ) 培養液中の血球等と菌を分離するために、 培養液の一部を一般的細菌が生 育する固形培地に接種して培養する。 固形培地上に増殖した菌はその後の同定検 査等に供されるが、 この時、 グラム染色所見で単一の菌種であり、 固形培地上の コロニーが均一な場合は、 血液中に存在していた菌の種類が単一 (純培養状) と 仮定し、 直ちに固形培地上の菌が同定検査、 感受性検査等に供されることがある。 一方、 グラム染色所見で複数の菌種が観察されたり、 固形培地上に明らかに異な つた形状のコロニーが増殖した場合は、 それぞれのコロニーを釣菌し、 単一菌形 状のコロニー (集落) のみが発育するようになるまで培養を繰り返す。  (4) In order to separate bacteria from blood cells and the like in the culture, a part of the culture is inoculated into a solid medium in which general bacteria grow and cultured. Bacteria grown on the solid medium are subjected to subsequent identification tests, etc.At this time, if the bacteria are a single bacterial species based on gram staining findings, and if the colonies on the solid medium are uniform, they will be present in the blood. Assuming that the type of bacteria used was single (pure culture), the bacteria on the solid medium may be immediately subjected to identification tests, susceptibility tests, etc. On the other hand, if multiple bacterial species are observed on the Gram staining findings, or if colonies with distinctly different shapes proliferate on the solid medium, each colony is picked up and a single fungal colony (community) is collected. Repeat the culture until only the cells develop.
( 5 ) 純培養されたコロニーを釣菌し、 生化学性状検査による菌種の同定、 ある いは抗菌薬感受性検査による治療薬の検索を行う。 上記のような従来の技術の菌検出法では、 検体の採取から菌の同定まで日数が 掛かっていた。 敗血症、 菌血症が疑われる場合には患者は重篤であることが多く、 早急に適切な化学療法が要求される。 しかし、 従来の方法では操作を簡略化して も血液培養試験で菌が検出された以降も、 その後の検査に最低 3〜4日は必要と するため、 その間患者は適切な治療が施されず大きな負担となっていた。 (5) The colonies cultured in pure culture are picked, and the bacterial species is identified by biochemical characterization, or the therapeutic drug is searched by antimicrobial susceptibility testing. In the conventional method for detecting bacteria as described above, it took a number of days from collection of the sample to identification of the bacteria. If sepsis or bacteremia is suspected, the patient is often serious and prompt chemotherapy is required. However, even if the conventional method is simplified, even after the bacteria are detected in the blood culture test, the subsequent test requires at least 3 to 4 days. It was a burden.
このような問題を解決するために、 培養液中の血球等と菌の分離が検討されて いた。 しかし、 これまで、 血液培養液中の血球と菌の分離方法については、 菌と 血球の比重の違いに基づいた血清分離剤入りスピッッなどを用いて簡便に菌と血 球を分離する方法は開発されてきたが、 分離効果は不充分で菌の画分に血球が残 存することが多く、 該画分を用いて直接菌の検査を行うことは困難であった。 結局、 従来は血液培養液中の血球等と菌を分離するには、 さらに培養を行う必 要があり、 迅速な検出を行うことはできなかった。 発明の開示  In order to solve such problems, separation of bacteria from blood cells and the like in a culture solution has been studied. However, to date, methods for separating blood cells from blood cells in blood cultures have been developed by a simple method of separating bacteria and blood cells using a spitting solution containing a serum-separating agent based on the difference in specific gravity between bacteria and blood cells. However, the separation effect was insufficient and blood cells often remained in the bacterial fraction, and it was difficult to directly test bacteria using the fraction. After all, conventionally, in order to separate bacteria from blood cells and the like in a blood culture solution, it was necessary to further culture, and rapid detection could not be performed. Disclosure of the invention
本発明は、 血液を検体として該検体に含まれる菌を検出するに際して、 培養液 中の血球等と菌を分離するために、 培養液の一部を一般的細菌が生育する固形培 地に接種して培養することなく、 液体培地培養液中に含まれる血球と菌を分離す る方法を提供することを目的とする。  The present invention relates to a method of inoculating a part of a culture solution into a solid medium in which general bacteria grow in order to separate bacteria from blood cells and the like in the culture solution when detecting bacteria contained in the sample using blood as a sample. An object of the present invention is to provide a method for separating blood cells and bacteria contained in a liquid culture medium without culturing the cells.
本発明者らは、 血液を検体として用いる液体培養試験において菌の発育が認め られた場合、 該培養液中の菌の同定に際して、 血液成分である血球等が菌種の同 定の妨げになることに鑑み、 鋭意検討の結果、 血球等と菌が含まれる液体培地培 養液をアルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若 しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液と接触させる ことにより血球等を除去し、 血球等と菌を分離することができることを見出し本 発明を完成するに至った。  The present inventors have found that when bacterial growth is observed in a liquid culture test using blood as a specimen, blood cells, which are blood components, hinder the identification of bacterial species when identifying bacteria in the culture solution. In view of this, as a result of diligent studies, it was found that the liquid culture medium containing blood cells, etc. and bacteria was treated with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine. Alternatively, the present inventors have found that blood cells and the like can be removed by bringing them into contact with a mixed aqueous solution thereof and bacteria can be separated from the blood cells and the like, thereby completing the present invention.
すなわち、 本発明は、 以下のとおりである。  That is, the present invention is as follows.
( 1 ) 血液中の菌を検出する際の血液中の菌の液体培地培養液中に含まれる血 球と菌を分離する方法であって、 血液中の菌の液体培地培養液をアル力リ金属の 水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァ ミンの水溶液、 あるいはこれらの混合水溶液と接触させることにより血球を除去 することを含む、 血球と菌を分離する方法。 (1) A method for separating bacteria and blood cells contained in a liquid culture medium of bacteria in blood when detecting bacteria in blood, comprising the steps of: Blood cells are removed by contact with metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine aqueous solution, or a mixed aqueous solution of these. A method of separating blood cells and bacteria.
(2) 前記水溶液の pHが 11以上である、 (1) の分離方法。  (2) The separation method according to (1), wherein the pH of the aqueous solution is 11 or more.
(3) 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はアミン、 あるいはこれらの混合物の濃度が 0.01 M〜l. 0 Mである、 (2) の血球と菌の分離方法。  (3) The concentration of the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the amine, or a mixture thereof, of 0.01 M to 1.0 M, How to separate blood cells and bacteria.
(4) 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化力'〕ゥムおよびト リエ夕ノールァミンからなる群から選択される、 (1) 〜 (3) のいずれかの血 球と菌の分離方法。  (4) The alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine is selected from the group consisting of sodium hydroxide, hydroxylating ability]] triam and triethanolamine. The method for separating blood cells and bacteria according to any one of (1) to (3).
(5) 血液中の菌を検出する方法であって、 被験血液をアルカリ金属の水酸化 物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの 水溶液、 あるいはこれらの混合水溶液と接触させることにより該血液中の血球を 除去し、 血球を除去した血液中の菌を検出する方法。 , (5) A method for detecting bacteria in blood, wherein the test blood is an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof. A method for removing blood cells from said blood by contacting said blood cells and detecting bacteria in blood from which blood cells have been removed. ,
(6) 血液中の菌を検出する方法であって、 被験血液を接種した液体培地を培 養し菌を増殖させ、 該液体培地をァ0 /カリ金属の水酸化物若しくは炭酸塩、 アル カリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれら の混合水溶液と接触させることにより該液体培地中の血球を除去し、 血球を除去 した液体培地中の菌を検出する方法。 (6) A method for detecting bacteria in blood, comprising culturing a liquid medium inoculated with a test blood to grow the bacteria, and culturing the liquid medium with hydroxide or carbonate of a / potassium metal, alkali metal. A method for detecting bacteria in the liquid medium from which the blood cells have been removed by removing the blood cells in the liquid medium by contacting with an aqueous solution of an earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof.
(7) 前記水溶液の pHが 11以上である、 (5) または (6) の菌を検出する方 法。  (7) A method for detecting the bacterium according to (5) or (6), wherein the pH of the aqueous solution is 11 or more.
(8) 前記アルカリ 属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はアミン、 あるいはこれらの混合物の濃度が 0.01 M〜l. 0 Mである、 (5) 〜 (7) のいずれかの菌を検出する方法。  (8) The concentration of the alkali hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine, or a mixture thereof is 0.01 M to 1.0 M. (7) A method for detecting any of the bacteria according to (1).
(9) 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化カリウムおよびト リエタノールアミンからなる群から選択される、 (5) 〜 (8) のいずれかの菌 を検出する方法。  (9) the alkali metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine; 5) A method for detecting any of the bacteria of (8).
(1 0) 検出する菌が、 メチシリン耐性黄色ブドウ球菌、 大腸菌 0157株、 A群 溶連菌からなる群から選択される、 (5) 〜 (9) のいずれかの菌を検出する方 法。 ( 1 1 ) アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化 物若しくは炭酸塩、 又はァミン、 ならびに菌を検出するための試薬を含む、 血液 中の菌を分離検出するためのキット。 (10) A method for detecting a bacterium according to any one of (5) to (9), wherein the bacterium to be detected is selected from the group consisting of methicillin-resistant Staphylococcus aureus, Escherichia coli 0157 strain, and group A streptococcus. (11) For separating and detecting bacteria in blood, including hydroxides or carbonates of alkali metals, hydroxides or carbonates of alkaline earth metals, or amines, and reagents for detecting bacteria. kit.
( 1 2 ) さらに、 菌を含む血液を培養するための液体培地を含む、 (1 1 ) 記 載の血液中の菌を分離検出するためのキット。  (12) The kit for separating and detecting bacteria in blood according to (11), further comprising a liquid medium for culturing blood containing bacteria.
( 1 3 ) 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水 酸化物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化カリウムおよび トリエタノールァミンからなる群から選択される、 (1 1 ) または (1 2 ) の血 液中の菌を分離検出するためのキット。  (13) The hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine. A kit for separating and detecting bacteria in the blood of (11) or (12).
( 1 4 ) 菌を検出するための試薬がメチシリン耐性黄色ブドウ球菌、 大腸菌 01 57株、 A群溶連菌からなる群から選択される菌を検出するための試薬である、 (14) The reagent for detecting bacteria is a reagent for detecting bacteria selected from the group consisting of methicillin-resistant Staphylococcus aureus, Escherichia coli 0157 strain, and group A streptococcus,
( 1 1 ) 〜 (1 3 ) のいずれかの血液中の菌を分離検出するためのキット。 A kit for separating and detecting bacteria in blood according to any one of (11) to (13).
好適と考える本発明の実施の形態を、 その作用効果を示して詳細に説明する。 本発明において、 被験体として用いる動物種は限定されず、 ヒト、 ゥシ、 ゥマ、 ブ夕、 ィヌ、 ネコ等の敗血症、 菌血症等の疾患にかかる動物のものを用いる。 本 発明の対象となる菌としては、 メチシリン耐性黄色ブドウ球菌 (MRSA) 、 大腸菌、 緑膿菌、 腸球菌、 カンジダ、 溶連菌等の連鎖球菌等が挙げられるが、 特に限定は されず、 上記疾病に関するあらゆる細菌 ·真菌などがこれにあたる。  Preferred embodiments of the present invention will be described in detail with reference to the effects thereof. In the present invention, the animal species to be used as a subject is not limited, and an animal species having a disease such as sepsis or bacteremia, such as human, pest, poma, bush, dog, cat, etc. is used. Examples of the bacterium to be used in the present invention include methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa, Enterococcus, Candida, Streptococcus such as streptococcus, etc., but are not particularly limited. All bacteria and fungi correspond to this.
まず、 細菌培養用液体培地約 30mL〜100mLに被験体より採取した血液 2〜10mL接 種し、 直ちに 30〜37°Cで培養する。 この際、 液体培地としてトリプチケースソィ ブロス、 ブレインハートインフュージョンブロス、 普通ブイヨン、, ミューラーヒ ントンブロス、 ハートインフュージョンブロスなどが挙げられるが、 特に限定さ れるものではない。 次に、 菌の発育が認められるまで 1〜14日間毎日観察を行う。 菌の発育は、 培地の濁度、 細菌による培地中のガスの発生、 pHの変化、 培地中の 炭酸ガス濃度の変化などによって判断する。 菌の発育が確認された後、 培養液を 採取してグラム染色及び形態観察が行われ、 染色所見と形態の特徴により大まか な菌種の分類、 及び観察される菌が単一か複数かなどを確認する。  First, inoculate 2 to 10 mL of blood collected from a subject into approximately 30 to 100 mL of a liquid medium for bacterial culture, and immediately culture at 30 to 37 ° C. In this case, the liquid medium includes, but is not limited to, trypticase soy broth, brain heart infusion broth, ordinary bouillon, Mueller-Hinton broth, heart infusion broth, and the like. Next, observe daily for 1 to 14 days until bacterial growth is observed. Bacterial growth is determined by the turbidity of the medium, the generation of gas in the medium by the bacteria, changes in pH, and changes in the concentration of carbon dioxide in the medium. After the growth of the bacteria is confirmed, the culture solution is collected and subjected to Gram staining and morphological observation.The general classification of the bacterial species based on the staining findings and morphological characteristics, and whether or not the observed bacteria is single or multiple, etc. Check.
その後、 血球等と細菌を含む液体培地培養液を、 アルカリ金属の水酸化物若し くは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液と混合し接触させる。 アルカリ金属またはアルカリ土類金属の水酸化物の例として、 水酸化リチウム、 水酸化ナトリウム、 水酸化カリウム、 水酸化ルビジウム、 水酸化セシウム、 水酸 化マグネシウム、 水酸化カルシウム、 水酸化ストロンチウム、 水酸化バリウムを 挙げることができ、 これらのうち、 水酸化リチウム、 水酸化ナトリウム及び水酸 化カリウムが好ましい。 また、 アルカリ金属またはアルカリ土類金属の炭酸塩の 例として、 炭酸リチウム、 炭酸ナトリウム、, 炭酸カリウム、 炭酸ルビジウム、 炭 酸セシウム、 炭酸マグネシウム、 炭酸カルシウム、 炭酸ストロンチウム、 炭酸バ リウムを挙げることができ、 これらのうち、 炭酸リチウム、 炭酸ナトリウム及び 炭酸カリウムが好ましい。 また、 本発明の方法に用いることができるァミンの例 として、 トリエタノールァミン、 トリス (ヒドロキシメチル) ァミノメタン、 水 酸化ァミンなどを挙げることができる。 Thereafter, the liquid culture medium containing blood cells and bacteria is mixed with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine aqueous solution, or a mixed aqueous solution thereof. Mix and contact. Examples of alkali metal or alkaline earth metal hydroxides include lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, magnesium hydroxide, calcium hydroxide, strontium hydroxide, and hydroxide. Barium can be mentioned, and among these, lithium hydroxide, sodium hydroxide and potassium hydroxide are preferable. Examples of alkali metal or alkaline earth metal carbonates include lithium carbonate, sodium carbonate, potassium carbonate, rubidium carbonate, cesium carbonate, magnesium carbonate, calcium carbonate, strontium carbonate, and barium carbonate. Of these, lithium carbonate, sodium carbonate and potassium carbonate are preferred. Examples of the amine that can be used in the method of the present invention include triethanolamine, tris (hydroxymethyl) aminomethane, and hydroxylamine.
液体培地培養液はそのままアルカリ金属水酸化物等と接触させてもよいし、 一 旦、 液体培地培養液の適当量を遠心分離し、 上清を捨て、 血球と菌が混在する沈 渣を得て、 この沈渣をアルカリ金属水酸化物等と接触させてもよい。 この際の遠 心分離は、 800〜5000Gで行うことが望ましい。 この沈渣には血球と菌が混在する。 また、 免疫学的手法により、 すなわち菌に対する抗体を用いた検出方法により 菌を検出する場合は、 血球と菌の混合物 (溶液または沈查) をアルカリ金属の水 酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はアミ ンの水溶液、 あるいはこれらの混合水溶液と接触させる前に、 上述のように菌を 増殖させることが好ましい。 一方、 菌の遺伝子を増幅させて菌を検出する PCR等 の遺伝子検査では、 菌を増殖させることなく、 血球と菌の混合物をアルカリ金属 の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又は ァミンの水溶液、 あるいはこれらの混合水溶液と接触させることにより、 血球の みを除去でき血球の影響なしに菌の遺伝子を増幅させることができ、 より迅速に 菌の存在を検出することができる。 この際、 血液をそのまま、 または生理食塩水、 適当な緩衝液等で希釈した後に、 アルカリ金属の水酸化物若しくは炭酸塩、 アル カリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれら の混合水溶液と接触させて、 血液中の菌の遺伝子を検出することができる。 また、 血液または生理食塩水、 適当な緩衝液等で希釈した血液を遠心分離し、 血球と菌 を含む沈查を得て、 その沈査をアルカリ金属の水酸化物若しくは炭酸塩、 アル力 リ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの 混合水溶液と接触させても、 血液中の菌の遺伝子を検出することができる。 接触させる温度、 時間は特に限定されないが、 血液中の血球が破壌され、 血球 を構成する成分が溶解される条件ならばよく、 好ましくは 2〜37 :、 数秒〜数分 程度がよく、 攪拌などにより均一に接触させることはより効果を高めるためには 望ましい。 この結果、 血球は破壊され、 血球を構成する成分は上記水溶液に溶解 されるが、 菌は溶解されないため、 これを遠心分離することにより、 血球などの 夾雑物質を効率よく分離することができ、 遠心分離の沈渣からは高純度の菌を得 ることができる。 The liquid culture broth may be directly contacted with an alkali metal hydroxide or the like, or, once, an appropriate amount of the liquid culture broth is centrifuged, and the supernatant is discarded to obtain a precipitate in which blood cells and bacteria are mixed. Then, the precipitate may be brought into contact with an alkali metal hydroxide or the like. The centrifugal separation at this time is desirably performed at 800 to 5000G. The sediment contains blood cells and bacteria. When bacteria are detected by an immunological method, that is, by a detection method using an antibody against the bacteria, a mixture (solution or precipitate) of the blood cells and the bacteria is converted to an alkali metal hydroxide or carbonate, alkaline earth metal, or the like. It is preferable to grow the bacteria as described above before contacting with an aqueous solution of a metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof. On the other hand, genetic tests such as PCR that amplify bacterial genes and detect bacteria, such as PCR, use a mixture of blood cells and bacteria with hydroxides or carbonates of alkali metals and hydroxides of alkaline earth metals without growing the bacteria. By contacting it with an aqueous solution of a substance, carbonate, or amine, or a mixed solution of these, it is possible to remove only blood cells and amplify bacterial genes without the influence of blood cells, and detect the presence of bacteria more quickly can do. At this time, the blood is used as it is or after being diluted with physiological saline or a suitable buffer, etc., and then an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine. Alternatively, the bacterial gene in the blood can be detected by contact with a mixed aqueous solution thereof. In addition, blood or blood diluted with physiological saline or an appropriate buffer is centrifuged to obtain a precipitate containing blood cells and bacteria, and the precipitate is subjected to alkali metal hydroxide or carbonate, alkaline force. Bacterial genes in the blood can also be detected by contact with an aqueous solution of a hydroxide or carbonate of an alkaline earth metal, or an amine, or a mixed aqueous solution thereof. The temperature and time for contacting are not particularly limited, but any conditions may be used as long as blood cells in the blood break down and components constituting the blood cells are dissolved, preferably 2 to 37: several seconds to several minutes, and stirring is performed. It is desirable to make the contact more uniform, in order to further enhance the effect. As a result, the blood cells are destroyed, and the components constituting the blood cells are dissolved in the aqueous solution, but the bacteria are not dissolved.Thus, by centrifuging the cells, it is possible to efficiently separate contaminants such as blood cells. High-purity bacteria can be obtained from the sediment of centrifugation.
また、 接触させるアルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属 の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液 の pHは、 血液中の血球が破壌され、 血球を構成する成分が溶解されるが菌の構成 成分が溶解されない pHならばよく、 該水溶液と接触させる血球および菌の混合物 が沈查の場合は、 好ましくは 9以上であり、 さらに好ましくは 10以上であり、 特 に好ましくは 11以上である。 血球と菌を含む液体培地培養液をアルカリ金属の水 酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はアミ ンの水溶液、 あるいはこれらの混合水溶液と接触させるとき、 または血液をその まま、 または生理食塩水、 適当な緩衝液等で希釈した後に、 アルカリ金属の水酸 化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はアミン の水溶液、 あるいはこれらの混合水溶液と接触させるときは、 接触後の溶液の最 終 pHが好ましくは 9以上、 さらに好ましくは 10以上、 特に好ましくは 1 1以上にな るようにアル力リ金属の水酸化物若しくは炭酸塩、 アル力リ土類金属の水酸化物 若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液を調整して おけばよい。 この調整は、 接触に用いる血球と菌を含む溶液およびアルカリ金属 の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又は ァミンの水溶液、 あるいはこれらの混合水溶液の体積比により適宜変更できる。 このときの、 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属 の水酸化物若しくは炭酸塩、 又はァミンの水溶液の濃度は、 pHが上記範囲になる ような濃度が好ましい。 その濃度としては、 該水溶液と接触させる血球および菌 の混合物が沈査の場合は、 0. 01 M〜l. 0 Mが好ましい。 血球と菌を含む液体培地 培養液をアルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物 若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液と接触させ るとき、 または血液をそのまま、 もしくは生理食塩水、 適当な緩衝液等で希釈し た後に、 アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物 若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの混合水溶液と接触させ るときは、 接触後の溶液の最終濃度が上記濃度になるように接触させるアルカリ 金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァミン、 あるいはこれらの混合水溶液の濃度を調整しておけばよい。 この調 整は、 接触に用いる血球と菌を含む溶液およびアル力リ金属の水酸化物若しくは 炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あ るいはこれらの混合水溶液の体積比により適宜変更できる。 例えば、 血球と菌を 含む被験液 lOmLと水酸化ナトリゥム溶液 lOmLを混合し、 水酸化ナトリゥムの最終 濃度を 0. 1Mにする場合には、 0. 2Mに調整した水酸化ナトリゥム溶液 lOmLを血球と 菌を含む被験液 lOmLと接触混合すればよい。 The pH of the alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the aqueous solution of amine, or the pH of the mixed aqueous solution thereof is such that blood cells in blood break down and blood cells The pH may be any pH at which the constituents of the bacteria are dissolved but the constituents of the bacteria are not dissolved.If the mixture of blood cells and bacteria to be brought into contact with the aqueous solution is sedimented, the pH is preferably 9 or more, and more preferably 10 or more. And particularly preferably 11 or more. When a liquid culture medium containing blood cells and bacteria is brought into contact with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine aqueous solution, or a mixed aqueous solution thereof, or As is, or after dilution with physiological saline or a suitable buffer, etc., and then an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine aqueous solution, or a mixture thereof. When bringing into contact with an aqueous solution, the final pH of the solution after the contact is preferably 9 or more, more preferably 10 or more, particularly preferably 11 or more, so that the final pH of the solution is at least 11. An aqueous solution of hydroxide or carbonate of alkaline earth metal or amine, or a mixed aqueous solution thereof may be prepared. This adjustment depends on the volume ratio of the solution containing blood cells and bacteria used for the contact and the hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or the aqueous solution of amine, or a mixed aqueous solution thereof. It can be changed as appropriate. At this time, the concentration of the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the aqueous solution of the amine is preferably such that the pH falls within the above range. When the mixture of blood cells and bacteria to be brought into contact with the aqueous solution is sedimentation, the concentration is preferably 0.01 M to 1.0 M. Liquid medium containing blood cells and bacteria When the culture solution is brought into contact with an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an aqueous solution of amine, or a mixed aqueous solution thereof, or the blood as it is or physiological saline When contacting with an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof after dilution with an appropriate buffer, etc. The concentration of the alkali metal hydroxide or carbonate, the alkaline earth metal hydroxide or carbonate, or the amine, or the mixed aqueous solution thereof is adjusted so that the final concentration of the solution after the contact is the above concentration. It should be adjusted. This adjustment is carried out using a solution containing blood cells and bacteria used for the contact, and a hydroxide or carbonate of alkaline metal, a hydroxide or carbonate of alkaline earth metal, or an aqueous solution of amine or a mixture thereof. It can be appropriately changed depending on the volume ratio of the aqueous solution. For example, to mix lOmL of test solution containing blood cells and bacteria with lOmL of sodium hydroxide solution to make the final concentration of sodium hydroxide 0.1M, add lOmL of sodium hydroxide solution adjusted to 0.2M to blood cells. What is necessary is just to contact and mix with 10 mL of test liquid containing bacteria.
血球が破壊溶解された溶液から遠心分離により最終的に得られた菌は、 MRSA- L A 「生研」 (デン力生研社製) 、 病原大腸菌免疫血清 0157 「生研」 (デン力生研 社製) 、 A群溶連菌検出用キット、 Aストレプト AD 「生研」 (デン力生研社製) 等 の市販の凝集法、 ELISA法、 ウェスタンプロット法による細菌検査試薬を用いて 検出することができる。 また、 菌の DNAを PCR法等により検出する場合も、 菌の DN Aを公知手段で抽出し、 市販の DNA検査試薬を用いて、 検出することができる。 従って、 本発明で用い得るアルカリ金属の水酸化物若しくは炭酸塩、 アルカリ 土類金属の水酸化物若しくは炭酸塩、 又はァミンおよび菌の検查試薬を組合わせ ることにより、 迅速かつ正確に血液中の菌を検出できる、 菌検出キットを構成す ることができる。  Bacteria finally obtained by centrifugation from the solution in which the blood cells were disrupted and lysed were MRSA-LA “Seiken” (manufactured by Denrikseiken), pathogenic Escherichia coli immune serum 0157 “Seiken” (manufactured by Denkiseiken), It can be detected using a commercially available agglutination method such as a group A streptococcus detection kit, A-Strept AD “Seiken” (manufactured by Denrikseiken), an ELISA method, or a Western blot method. In addition, when bacterial DNA is detected by PCR or the like, the DNA of the bacteria can be extracted by known means and detected using a commercially available DNA test reagent. Therefore, by combining the hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or a reagent for detecting an amine or a bacterium, which can be used in the present invention, it is possible to rapidly and accurately detect the blood or blood. A bacteria detection kit capable of detecting the above bacteria can be configured.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明の実施例に基づきさらに具体的に説明する。 もっとも、 本発明は 下記実施例に限定されるものではない。  Hereinafter, a more specific description will be given based on examples of the present invention. However, the present invention is not limited to the following examples.
〔実施例 1〕 血液中の MRSA (メチシリン耐性黄色ブドウ球菌) の検出 血液培養: 抗凝固剤を添加したゥマ血液 lOmLに匿 SA (メチシリン耐性黄色ブ ドウ球菌) 、 または MSSA (メチシリン感受性黄色ブドウ球菌) を 108ciuZmL含む 菌液を 1白金耳量 (0. 001〜0. 0015mL) 添加し、 このうち 8mLを血液培養用液体 培地入りボトル (BBLセプティチェック TSB (登録商標) ) に接種し、 35°Cで一晩 培養した。 [Example 1] Detection of MRSA (methicillin-resistant Staphylococcus aureus) in blood Blood cultures: anticoagulant was added © Ma blood lOmL the anonymous SA (methicillin-resistant staphylococci), or MSSA 1 loopful of bacterial suspension containing 10 8 ciuZmL the (methicillin-susceptible Staphylococcus aureus) (0.001 .0015 mL), 8 mL of which was inoculated into a bottle (BBL Septicheck TSB (registered trademark)) containing a liquid culture medium for blood culture, and cultured overnight at 35 ° C.
MRSA株: ANJ- 10 [niecA (+) XPCR, MIPPC (R) /KBディスク]  MRSA strain: ANJ-10 [niecA (+) XPCR, MIPPC (R) / KB disc]
ANJ-12 [fflecA (+) /PCR, MIPPC (R) /KBディスク] ANJ-12 [fflecA (+) / PCR, MIPPC (R) / KB disc]
ANJ-131 [mecA (+) PCR, MIPPC (R) /KBディスク] ANJ-131 [mecA (+) PCR, MIPPC (R) / KB disc]
ATCC43300 [iecA (+) /PCR, MIPPC (R) /KBディスク] ATCC43300 [iecA (+) / PCR, MIPPC (R) / KB disc]
MSSA株: ATCC25923 [mecA (-) XPCR, MIPPC (S) /KBディスク] MSSA strain: ATCC25923 [mecA (-) XPCR, MIPPC (S) / KB disc]
FDA209P [mecA (— ) /PCR, MIPPC (S) /KBディスク] FDA209P [mecA (—) / PCR, MIPPC (S) / KB disk]
培養液 lOmLを採取した後、 これを 1500Gで 15分間遠心した。 ここで得られた沈 渣は、 赤血球の存在により赤色であり、 一部を採取してグラム染色後に顕微鏡観 察したところ、 グラム陽性球菌と血球が観察された。  After collecting 10 mL of the culture solution, this was centrifuged at 1500 G for 15 minutes. The sediment obtained here was red due to the presence of erythrocytes. When a part of the sediment was sampled and observed under a microscope after gram staining, gram-positive cocci and blood cells were observed.
遠心後、 上清を廃棄して残った沈渣に 0. 1M水酸化ナトリウム溶液を 5mL添加し、 試験管ミキサーを用いて 30秒間攪拌を行つた。  After centrifugation, the supernatant was discarded, and 5 mL of a 0.1 M sodium hydroxide solution was added to the remaining precipitate, followed by stirring for 30 seconds using a test tube mixer.
攪拌後、 再び 1500Gで 15分間遠心した。  After stirring, the mixture was centrifuged again at 1500 G for 15 minutes.
遠心後、 上清を廃棄し、 沈渣を得た。 ここで得られた沈渣は白色で、 顕微鏡観 察では血球は観察されなかった。  After centrifugation, the supernatant was discarded to obtain a sediment. The sediment obtained here was white, and no blood cells were observed under a microscope.
得られた沈渣から 2白金耳量の沈渣を採取し、 これを検体として MRSA- LA 「生 研」 (デン力生研社製) を用いた PBP2' (ペニシリン結合蛋白(Penic i l l in bind i ng prote in)検出試験を行ったところ、 MRSAを添加した血液を接種した血液培養 液由来の菌は PBP2'陽性と判定され、 MSSAを添加した血液を接種した血液培養液 由来の菌は PBP2'陰性であった。  Two platinum loops of sediment were collected from the obtained sediment, and this was used as a sample for PBP2 '(Penicillin in binding protein) using MRSA-LA “Seiken” (Denrik Seiken). in) In the detection test, bacteria derived from blood cultures inoculated with MRSA-added blood were determined to be PBP2'-positive, and bacteria from blood cultures inoculated with MSSA-added blood were PBP2'-negative. there were.
結果を表 1に示す。 表 1 菌 株 PBP2'検出結果 判Table 1 shows the results. table 1 Strain PBP2 'detection result
RSA ANJ- 10 性 メチシリ ン耐性菌  RSA ANJ-10 sex methicillin resistant bacteria
ANJ- 12 性 メチシリ ン耐性菌  ANJ-12 sex methicillin resistant bacteria
ANJ- 131 性 メチシリ ン耐性菌  ANJ-131 methicillin resistant bacteria
ATCC43300 性 メチシリン耐性菌  ATCC43300 methicillin-resistant bacteria
MSSA ATCC25923 性 メチシリ ン感受性菌  MSSA ATCC25923 methicillin-sensitive bacteria
FDA209P 1生 メチシリン感受性菌  FDA209P 1 Raw methicillin-sensitive bacteria
〔実施例 2〕 血液中の大腸菌 0157の検出 [Example 2] Detection of E. coli 0157 in blood
以下の実施例は、 実際の臨床診断に直ちに適用可能な臨床検査法をあらわすも のではなく、 本発明を具体的に説明する上で行った実施例である。  The following examples do not represent a clinical test method that can be immediately applied to actual clinical diagnosis, but are examples performed to specifically explain the present invention.
血液培養: 抗凝固剤を添加したゥマ血液 10mLに大腸菌 0157、 または他の血清 型の大腸菌を 108cfu/mL含む菌液を 1白金耳量 (0. 001〜0. 0015mL) 添加し、 こ のうち 8mLを血液培養用液体培地入りボトル (BBLセプティチェック BHI (登録商 標) ) に接種し、 35°Cで一晩培養した。 Blood culture: Add 1 loopful (0.001 to 0.0015 mL) of a bacterial solution containing Escherichia coli 0157 or 10 8 cfu / mL of Escherichia coli of another serotype to 10 mL of poma blood supplemented with an anticoagulant. 8 mL of this was inoculated into a bottle (BBL SeptiCheck BHI (registered trademark)) containing a liquid culture medium for blood culture, and cultured overnight at 35 ° C.
大腸菌 0157株 : M- 02株 [0157: H7]  Escherichia coli 0157 strain: M-02 strain [0157: H7]
M- 03株 [0157: H7]  M-03 shares [0157: H7]
DK- 04株 [0157: H-]  DK- 04 strain [0157: H-]
M- 05株 [0157: H7]  M-05 stock [0157: H7]
大腸菌 026株 DK- 01株 [026: H-]  E. coli 026 strain DK-01 strain [026: H-]
DK- 06株 随1: H -]  DK-06 share 1 : H-]
M- EC- 1株 [01: H-]  M-EC- 1 share [01: H-]
培養液 10mLを採取した後、 これを 1500Gで 15分間遠心した。 ここで得られた沈 渣は、 赤血球の存在により赤色であり、 一部を採取してグラム染色後に顕微鏡観 察したところ、 グラム陰性短桿菌と血球が観察された。  After collecting 10 mL of the culture solution, this was centrifuged at 1500 G for 15 minutes. The sediment obtained here was red due to the presence of erythrocytes. When a part of the sediment was sampled and observed under a microscope after gram staining, gram-negative short bacilli and blood cells were observed.
遠心後、 上清を廃棄して残った沈渣に 0. 2M水酸化カリウム溶液を 5niL添加し、 試験管ミキサーを用いて 30秒間攪拌を行った。 攪拌後、 再び 1500Gで 15分間遠心 した。  After centrifugation, the supernatant was discarded, and 5 niL of a 0.2 M potassium hydroxide solution was added to the remaining precipitate, followed by stirring for 30 seconds using a test tube mixer. After stirring, the mixture was centrifuged again at 1500 G for 15 minutes.
遠心後、 上清を廃棄し、 沈渣を得た。 ここで得られた沈渣は白色で、 顕微鏡観 察では血球は観察されなかった。 After centrifugation, the supernatant was discarded to obtain a sediment. The sediment obtained here is white and viewed under a microscope. On inspection, no blood cells were observed.
得られた沈渣に 0. 1Mリン酸緩衝液 pH7. 0を 0. lmL添加して菌の濃厚液を調製し、 これ検体として病原大腸菌免疫血清 0157 「生研」 (デン力生研社製) を用いたス ライド凝集反応試験を行ったところ、 大腸菌 0157を添加した血液を接種した血液 培養液由来の菌は凝集陽性と判定され、 0157以外の菌株を接種した血液培養液由 来の菌は陰性であった。  0.1 ml of 0.1 M phosphate buffer pH 7.0 was added to the obtained sediment to prepare a concentrated solution of bacteria, and pathogenic Escherichia coli immune serum 0157 “Seiken” (manufactured by Denriki Seiken) was used as the specimen. In a slide agglutination test, bacteria from blood cultures inoculated with E. coli 0157-added blood were determined to be positive for agglutination, while bacteria from blood cultures inoculated with strains other than 0157 were negative. there were.
結果を表 2に示す。 表 2 株 判 定  Table 2 shows the results. Table 2 Stock judgment
大腸菌 0157株 DK-02株 曰 性  E. coli 0157 strain DK-02 strain
DK-03株 性  DK-03 stock
DK-0 株 性  DK-0 stock
D 05株 性  D 05 stock sex
大腸菌 026 DK-01株 性  E. coli 026 DK-01 strain
大腸菌 O lll DK-06株 性  E. coli Ollll DK-06 strain
大腸菌 O l DK-EC 1株 ½ュ 性  E. coli Ol DK-EC 1 strain
〔実施例 3〕 A群溶連菌の検出 (Example 3) Detection of group A streptococcus
血液培養: 抗凝固剤を添加したゥサギ血液 lOinUこ A群溶連菌、 または他の群 の溶連菌を 108c iuZmL含む菌液を 1白金耳量 (0. 00 1〜0. 0015mL) 添加し、 この うち 8mLを血液培養用液体培地入りボトル (BBLセプティチェック TSB (登録商 標) ) に接種し、 35°Cで一晩培養した。 Blood cultures: anticoagulant was added Usagi blood lOinU this group A streptococci or other loopful of bacterial suspension containing 10 8 c iuZmL the streptococcus group (. 0. 00 1~0 0015mL) was added, this 8 mL of the mixture was inoculated into a bottle (BBL SeptiCheck TSB (registered trademark)) containing a liquid culture medium for blood culture, and cultured overnight at 35 ° C.
A群溶連菌株 T - 1株 Group A streptococcal strain T-1
T- 2株  T-2 shares
T - 3株  T-3 shares
T- 4株 B群溶連菌株: I a株 T-4 shares Group B streptococcus: Ia strain
: I I株  : I I shares
: I I I株  : I I I shares
培養液 10mLを採取した後、 これを 1500Gで 15分間遠心した。 ここで得られた沈 渣は、 赤血球の存在により赤色であり、 一部を採取してグラム染色後に顕微鏡観 察したところ、 グラム陽性連鎖状の球菌と血球が観察された。  After collecting 10 mL of the culture solution, this was centrifuged at 1500 G for 15 minutes. The sediment obtained here was red due to the presence of erythrocytes. When a part of the sediment was collected and observed under a microscope after gram staining, gram-positive linked cocci and hemocytes were observed.
遠心後、 上清を廃棄して残った沈渣に 0. 05Mトリエタノールァミン、 0. 1M NaCl 溶液を 5mL添加し、 試験管ミキサーを用いて 30秒間攪拌を行った。 攪拌後、 再び 1 500Gで 15分間遠心した。  After centrifugation, the supernatant was discarded, and 5 mL of a 0.05 M triethanolamine and 0.1 M NaCl solution was added to the remaining sediment, followed by stirring for 30 seconds using a test tube mixer. After stirring, the mixture was centrifuged again at 1500 G for 15 minutes.
遠心後、 上清を廃棄し、 沈渣を得た。 ここで得られた沈渣は白色で、 顕微鏡観 察では血球は観察されなかった。  After centrifugation, the supernatant was discarded to obtain a sediment. The sediment obtained here was white, and no blood cells were observed under a microscope.
得られた沈渣に 1 %酢酸溶液 5 mLを添加して遠心し、 得られた沈渣を検体とし て A群溶連菌検出用キット、 Aストレプト AD 「生研」 (デン力生研社製) を用いた スライドラテックス凝集反応試験を行ったところ、 A群溶連菌を添加した血液を 接種した血液培養液由来の検体は陽性と判定され、 B群溶連菌を接種した血液培 養液由来の検体は陰性であった。 結果を表 3に示す。 表 3 菌 一株 判  Add 5 mL of 1% acetic acid solution to the obtained sediment, centrifuge, and use the obtained sediment as a sample, slide using kit for detection of group A streptococcus, A Strept AD “Seiken” (Denrik Seiken) In the latex agglutination test, a sample derived from a blood culture inoculated with blood to which group A streptococci had been added was determined to be positive, and a sample derived from a blood culture inoculated with group B streptococcus was negative. Table 3 shows the results. Table 3 Bacteria one strain
A群溶連菌株 T- 1 株 性  Group A streptococcal strain T-1
T- 2株 性  T-2 shares
T- 3株 性  T-3 shares
T-4株 性  T-4 strain
B群溶連菌株 I a株 性  Group B streptococcus Ia strain
Π株 性  Stock
m株 性 れらの結果は、 本発明の方法により血球と菌を含む培養液から血球を除去し. 精度よく迅速に菌を検出できることを示す。 These results indicate that blood cells were removed from a culture containing blood cells and bacteria by the method of the present invention. This shows that bacteria can be detected quickly and accurately.
産業上の利用可能性 Industrial applicability
実施例に示すように、 アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類 金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液と接触させることにより血 液中の菌を検出する際の血液中の、 または血液中の菌の液体培地培養液中に含ま れる血球を除去することにより血球と菌を効率よく分離することができる。 特に、 前記水溶液の pHを 1 1以上とすることにより、 さらに効率よく血球と菌を 分離することができる。  As shown in the Examples, when the bacteria in the blood are detected by contacting with an aqueous solution of an alkali metal hydroxide or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine, By removing the blood cells contained in the liquid culture medium of the bacteria in the blood or in the blood, the blood cells and the bacteria can be efficiently separated. In particular, by setting the pH of the aqueous solution to 11 or more, blood cells and bacteria can be more efficiently separated.
また、 前期アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はァミンの濃度を 0. 01 M〜l . 0 Mとすることにより、 さ らに効率よく血球と菌を分離することができる。  The concentration of the hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the concentration of the amine is 0.01 M to 1.0 M, so that the blood cells can be more efficiently used. And bacteria can be separated.
本明細書に引用されたすベての刊行物は、 その内容の全体を本明細書に取 り込むものとする。 また、 添付の請求の範囲に記載される技術思想および発 明の範囲を逸脱しない範囲内で本発明の種々の変形および変更が可能である ことは当業者には容易に理解されるであろう。 本発明はこのような変形およ び変更をも包含することを意図している。 All publications cited herein are incorporated by reference in their entirety. It will be readily understood by those skilled in the art that various modifications and changes of the present invention are possible without departing from the technical concept and the scope of the invention described in the appended claims. . The present invention is intended to cover such modifications and variations.

Claims

請求の範囲 The scope of the claims
1 . 血液中の菌を検出する際の血液中の菌の液体培地培養液中に含まれる血球 と菌を分離する方法であって、 血液中の菌の液体培地培養液をアルカリ金属の水 酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はアミ ンの水溶液、 あるいはこれらの混合水溶液と接触させることにより血球を除去す ることを含む、 血球と菌を分離する方法。  1. A method for separating bacteria and blood cells contained in a liquid culture medium of bacteria in blood when detecting bacteria in blood, the method comprising: A method for separating blood cells from bacteria, which comprises removing blood cells by contacting an aqueous solution of a substance or carbonate, an alkaline earth metal hydroxide or carbonate, or an amine, or a mixed aqueous solution thereof.
2 . 前記水溶液の ρΗが 11以上である、 請求項 1記載の分離方法。  2. The separation method according to claim 1, wherein ρΗ of the aqueous solution is 11 or more.
3 . 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化 物若しくは炭酸塩、 又はァミン、 あるいはこれらの混合物の濃度が 0. 01 Μ〜1. 0 Μである、 請求項 2記載の血球と菌の分離方法。  3. The concentration of the hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or an amine, or a mixture thereof, is 0.011 to 1.0Μ. The method for separating blood cells and bacteria according to the above.
4 . 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化 物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化カリウムおよびトリ エタノールァミンからなる群から選択される、 請求項 1〜3のいずれか 1項記載 の血球と菌の分離方法。  4. The alkali metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine. The method for separating blood cells and bacteria according to any one of claims 1 to 3.
5 . 血液中の菌を検出する方法であって、 被験血液をアルカリ金属の水酸化物 若しくは炭酸塩、 アルカリ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水 溶液、 あるいはこれらの混合水溶液と接触させることにより該血液中の血球を除 去し、 血球を除去した血液中の菌を検出する方法。  5. A method for detecting bacteria in blood, which comprises subjecting the test blood to a hydroxide or carbonate of an alkali metal, a hydroxide or carbonate of an alkaline earth metal, an aqueous solution of amine, or a mixed aqueous solution thereof. A method of removing blood cells from the blood by contacting the blood cells with bacteria and detecting bacteria in the blood from which the blood cells have been removed.
6 . 血液中の菌を検出する方法であって、 被験血液を接種した液体培地を培養 し菌を増殖させ、 該液体培地をアルカリ金属の水酸化物若しくは炭酸塩、 アル力 リ土類金属の水酸化物若しくは炭酸塩、 又はァミンの水溶液、 あるいはこれらの 混合水溶液と接触させることにより該液体培地中の血球を除去し、 血球を除去し た液体培地中の菌を検出する方法。  6. A method for detecting bacteria in blood, comprising culturing a liquid medium inoculated with a test blood to proliferate the bacteria, and forming the liquid medium from a hydroxide or carbonate of an alkali metal or an alkaline earth metal. A method of removing blood cells in the liquid medium by contacting with an aqueous solution of hydroxide, carbonate, or amine, or a mixed aqueous solution thereof, and detecting bacteria in the liquid medium from which the blood cells have been removed.
7 . 前記水溶液の ρΗが 11以上である、 請求項 5または 6記載の菌を検出する方 法。  7. The method for detecting bacteria according to claim 5, wherein ρΗ of the aqueous solution is 11 or more.
8 . 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化 物若しくは炭酸塩、 又はァミン、 あるいはこれらの混合物の濃度が 0. 01 M〜l. 0 Μである、 請求項 5〜7のいずれか 1項記載の菌を検出する方法。  8. The concentration of the alkali metal hydroxide or carbonate, alkaline earth metal hydroxide or carbonate, or amine, or a mixture thereof, is 0.01 M to 1.0 M. A method for detecting the bacterium according to any one of claims 1 to 7.
9 . 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化 物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化カリウムおよびトリ エタノールァミンからなる群から選択される、 請求項 5〜 8のいずれか 1項記載 の菌を検出する方法。 9. The hydroxide or carbonate of the alkali metal, the hydroxide or carbonate of the alkaline earth metal, or the amine is sodium hydroxide, potassium hydroxide or triethanol. The method for detecting bacteria according to any one of claims 5 to 8, which is selected from the group consisting of ethanolamine.
1 0 . 検出する菌が、 メチシリン耐性黄色ブドウ球菌、 大腸菌 0157株、 A群溶 連菌からなる群から選択される、 請求項 5〜 9のいずれか 1項記載の菌を検出す る方法。  10. The method for detecting a bacterium according to any one of claims 5 to 9, wherein the bacterium to be detected is selected from the group consisting of methicillin-resistant Staphylococcus aureus, Escherichia coli 0157 strain, and group A streptococcus.
1 1 . アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸化物 若しくは炭酸塩、 又はァミン、 ならびに菌を検出するための試薬を含む、 血液中 の菌を分離検出するためのキッ卜。  Kits for separating and detecting bacteria in blood, including hydroxides or carbonates of alkali metals, hydroxides or carbonates of alkaline earth metals, or amines, and reagents for detecting bacteria. Uru.
1 2 . さらに、 菌を含む血液を培養するための液体培地を含む、 請求項 1 1記 載の血液中の菌を分離検出するためのキット。  12. The kit for separating and detecting bacteria in blood according to claim 11, further comprising a liquid medium for culturing blood containing bacteria.
1 3 . 前記アルカリ金属の水酸化物若しくは炭酸塩、 アルカリ土類金属の水酸 化物若しくは炭酸塩、 又はァミンが水酸化ナトリウム、 水酸化カリウムおよぴト リエ夕ノールァミンからなる群から選択される、 請求項 1 1または 1 2記載の血 液中の菌を分離検出するためのキット。  13. The hydroxide or carbonate of an alkali metal, the hydroxide or carbonate of an alkaline earth metal, or the amine is selected from the group consisting of sodium hydroxide, potassium hydroxide and triethanolamine. The kit for separating and detecting bacteria in blood according to claim 11 or 12.
1 4 . 菌を検出するための試薬がメチシリン耐性黄色ブドウ球菌、 大腸菌 0157 株、 A群溶連菌からなる群から選択される菌を検出するための試薬である、 請求 項 1 1〜1 3のいずれか 1項記載の血液中の菌を分離検出するためのキット。  14. The reagent according to any one of claims 11 to 13, wherein the reagent for detecting the bacterium is a reagent for detecting a bacterium selected from the group consisting of methicillin-resistant Staphylococcus aureus, Escherichia coli 0157 strain, and group A streptococcus. Or a kit for separating and detecting bacteria in blood according to claim 1.
PCT/JP2002/010982 2001-10-23 2002-10-23 Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood WO2003035899A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003538399A JP4227019B2 (en) 2001-10-23 2002-10-23 Method for separating blood cells and bacteria in blood and method for detecting bacteria in blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001325125 2001-10-23
JP2001-325125 2001-10-23

Publications (1)

Publication Number Publication Date
WO2003035899A1 true WO2003035899A1 (en) 2003-05-01

Family

ID=19141744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/010982 WO2003035899A1 (en) 2001-10-23 2002-10-23 Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood

Country Status (2)

Country Link
JP (1) JP4227019B2 (en)
WO (1) WO2003035899A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011530303A (en) * 2008-08-13 2011-12-22 ビオメリュー A culture medium that can distinguish S. aureus from coagulase-negative staphylococci
JP2013512685A (en) * 2009-12-08 2013-04-18 バイオカルティス、ソシエテ、アノニム Selective cell lysis
CN112805388A (en) * 2018-10-09 2021-05-14 公益财团法人筑波医疗中心 Method for detecting microorganism

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113103A1 (en) * 1982-12-27 1984-07-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Inhibition of reduction activities of leukocytes
WO1993025711A1 (en) * 1992-06-12 1993-12-23 Gen-Probe Incorporated Preparation of nucleic acid from blood
WO1994018828A1 (en) * 1993-02-25 1994-09-01 Abbott Laboratories Multipurpose reagent system for rapid lysis of whole blood samples

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0635972B2 (en) * 1986-11-27 1994-05-11 東亜医用電子株式会社 Method for classifying leukocytes by flow cytometry
JP3301646B2 (en) * 1993-03-19 2002-07-15 シスメックス株式会社 Reagent for immature cell measurement
JP3324050B2 (en) * 1994-10-31 2002-09-17 日本光電工業株式会社 Leukocyte classification reagent and leukocyte classification method
WO2001032828A2 (en) * 1999-10-29 2001-05-10 Pall Corporation Biological fluid processing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113103A1 (en) * 1982-12-27 1984-07-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Inhibition of reduction activities of leukocytes
WO1993025711A1 (en) * 1992-06-12 1993-12-23 Gen-Probe Incorporated Preparation of nucleic acid from blood
WO1994018828A1 (en) * 1993-02-25 1994-09-01 Abbott Laboratories Multipurpose reagent system for rapid lysis of whole blood samples

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011530303A (en) * 2008-08-13 2011-12-22 ビオメリュー A culture medium that can distinguish S. aureus from coagulase-negative staphylococci
JP2013512685A (en) * 2009-12-08 2013-04-18 バイオカルティス、ソシエテ、アノニム Selective cell lysis
JP2016127844A (en) * 2009-12-08 2016-07-14 バイオカルティス、ナームローゼ、フェンノートシャップBiocartis Nv Selective lysis of cells
US10308976B2 (en) 2009-12-08 2019-06-04 Koninklijke Philips N.V. Selective lysis of cells
US11072813B2 (en) 2009-12-08 2021-07-27 Koninklijke Philips N.V. Selective lysis of cells
CN112805388A (en) * 2018-10-09 2021-05-14 公益财团法人筑波医疗中心 Method for detecting microorganism

Also Published As

Publication number Publication date
JPWO2003035899A1 (en) 2005-02-10
JP4227019B2 (en) 2009-02-18

Similar Documents

Publication Publication Date Title
CN106460030A (en) Composition and method for stabilizing and maintaining the viability of hardy microorganisms
Nagdev et al. Determination of polymerase chain reaction efficiency for diagnosis of tuberculous meningitis in Chelex-100® extracted DNA samples
US8399649B2 (en) Methods of detecting and controlling mucoid Pseudomonas biofilm production
JP7535312B2 (en) Improved methods for preparing clinical samples for nucleic acid amplification - Patents.com
EP3190173A2 (en) Long-term storage medium for culturing obligate anaerobic bacteria or microaerobic bacteria under aerobic environment, and method of detecting obligate anaerobic bacteria or microaerobic bacteria using said medium
JP3571378B2 (en) Infectious disease diagnostic probe
JP3773633B2 (en) Analysis method and reagent for E. coli O157
WO2003035899A1 (en) Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood
EP1329718A2 (en) Methods and devices for collecting and preparing specimens for detection of mycobacteria and their antigens
US20180274005A1 (en) Cord blood therapy to treat chronic disease caused by l-form bacteria
EP0974658B1 (en) Probes for the diagnosis of infections caused by streptococcus pyogenes
JPH0795068B2 (en) Rapid detection method for bacterial and fungal infections
Koenraad et al. Methods for the detection of Campylobacter in sewage: evaluation of efficacy of enrichment and isolation media, applicability of polymerase chain reaction and latex agglutination assay
US20050089948A1 (en) Decontamination and concentration kit for mycobacteria
US20210180117A1 (en) Compositions and methods for detection of microorganisms
Gamboa et al. Rapid detection of Mycobacterium tuberculosis in respiratory specimens, blood and other non-respiratory specimens by amplification of rRNA
Aktayeva et al. Isolation, identification and use of strains of bacteria of the genus Bacillus in a microbiological test for the determination of antibiotics in milk
Mekni et al. Overview of Genetic Background Beyond Polysaccharide Intercellular Adhesion Production in Staphylococcus epidermidis
RU2203317C2 (en) Method of detection of bacillus anthracis in milk
Zbar et al. Detection of streptokinase production by Streptococcus pyogen using real time PCR
JP3914914B2 (en) Probe for diagnosis of infections caused by Streptococcus pyogenes
JP3914915B2 (en) Probe for diagnosis of infections caused by Streptococcus pyogenes
JP3914916B2 (en) Probe for diagnosis of infections caused by Streptococcus pyogenes
IL270342A (en) A method for determining bacterial susceptibility to antibiotics
Yarima et al. PHENOTYPIC DETECTION OF EXTENDED SPECTRUM BETA LACTAMASES IN ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE ISOLATED FROM PATIENTS AT THE FEDERAL TEACHING HOSPITAL GOMBE, GOMBE STATE, NIGERIA

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003538399

Country of ref document: JP

122 Ep: pct application non-entry in european phase